Abstract

Ten countries have reported pfhrp2/pfhrp3 gene deletions since the first observation of pfhrp2-deleted parasites in 2012. In a previous study (Watson et al., 2017), we characterised the drivers selecting for pfhrp2/3 deletions and mapped the regions in Africa with the greatest selection pressure. In February 2018, the World Health Organization issued guidance on investigating suspected false-negative rapid diagnostic tests (RDTs) due to pfhrp2/3 deletions. However, no guidance is provided regarding the timing of investigations. Failure to consider seasonal variation could cause premature decisions to switch to alternative RDTs. In response, we have extended our methods and predict that the prevalence of false-negative RDTs due to pfhrp2/3 deletions is highest when sampling from younger individuals during the beginning of the rainy season. We conclude by producing a map of the regions impacted by seasonal fluctuations in pfhrp2/3 deletions and a database identifying optimum sampling intervals to support malaria control programmes.

Highlights

  • Diagnostic testing of suspected malaria cases has more than doubled in the last 15 years, with 75% of suspected cases seeking treatment from the public health sector receiving a diagnostic test in 2017 (World Health Organization, 2018a)

  • We present an extended version of our previous model, which predicts that more false-negative rapid diagnostic tests (RDTs) due to pfhrp2 gene deletions are observed when monoclonal infections are more prevalent, with the highest proportion observed when sampling from younger children at the start of the rainy season

  • Our predictions suggest that the misdiagnosis of clinical cases due to pfhrp2-negative RDT results is heavily dependent on transmission intensity (Figure 1)

Read more

Summary

Introduction

Diagnostic testing of suspected malaria cases has more than doubled in the last 15 years, with 75% of suspected cases seeking treatment from the public health sector receiving a diagnostic test in 2017 (World Health Organization, 2018a). Much of this progress reflects the increased distribution of rapid diagnostic tests (RDTs), with the most commonly used RDTs targeting the P. falciparum protein HRP2 (PfHRP2). False-negative RDT results due to pfhrp2/3 gene deletions have been reported in 10 countries in sub-Saharan Africa (SSA) (World Health Organization, 2018b).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call